Co-Diagnostics Inc

NASDAQ:CODX   3:59:50 PM EDT
9.87
+0.20 (+2.07%)
Other Pre-Announcement

Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results

Published: 08/12/2021 21:13 GMT
Co-Diagnostics Inc (CODX) - Co-diagnostics Reports Strong Second Quarter 2021 Financial Results.
Sees Q3 Earnings per Share $0.19 to $0.22.
Sees Q3 Revenue $23 Million to $25 Million.
Q2 Revenue $27.4 Million.
Q2 Revenue Estimate $20.8 Million -- Refinitiv Ibes Data (analyst estimates).
Sees Q3 Diluted Earnings per Share Forecasted to Be in $0.19 to $0.22 Range.